X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-10-28 | ELVN | Hohl Benjamin | CFO | S - Sale+OE | $28.56 | -6,250 | 0 | -100% | -$178,485 | |||||
2024-10-18 | ELVN | Patel Anish | COO | S - Sale | $30.00 | -716 | 343,311 | 0% | -$21,483 | ||||||
2024-10-18 | ELVN | Lyssikatos Joseph P | CHIEF SCIENTIFIC OFFICER | S - Sale | $30.00 | -847 | 1,015,188 | 0% | -$25,413 | ||||||
2024-10-18 | ELVN | Kintz Samuel | Pres, CEO | S - Sale | $30.00 | -924 | 1,002,892 | 0% | -$27,723 | ||||||
| D | 2024-10-18 | ELVN | Hohl Benjamin | CFO | S - Sale+OE | $30.00 | -814 | 0 | -100% | -$24,422 | |||||
2024-10-18 | ELVN | Heyman Richard A. | Dir | S - Sale | $30.00 | -1,570 | 188,245 | -1% | -$47,104 | ||||||
| D | 2024-10-18 | ELVN | Collins Helen Louise | Chief Medical Officer | S - Sale+OE | $30.00 | -816 | 0 | -100% | -$24,482 | |||||
2024-10-15 | ELVN | Heyman Richard A. | Dir | S - Sale | $27.67 | -1,270 | 189,815 | -1% | -$35,143 | ||||||
| M | 2024-10-08 | ELVN | Lyssikatos Joseph P | CHIEF SCIENTIFIC OFFICER | S - Sale | $28.11 | -51,145 | 1,016,035 | -5% | -$1,437,585 | |||||
| M | 2024-10-08 | ELVN | Kintz Samuel | Pres, CEO | S - Sale | $28.07 | -29,977 | 1,003,816 | -3% | -$841,334 | |||||
| D | 2024-10-08 | ELVN | Ballal Rahul D. | Dir | S - Sale+OE | $28.17 | -10,420 | 22,341 | -32% | -$293,557 | |||||
| M | 2024-10-04 | ELVN | Lyssikatos Joseph P | CHIEF SCIENTIFIC OFFICER | S - Sale | $27.54 | -10,229 | 1,067,180 | -1% | -$281,664 | |||||
| M | 2024-10-04 | ELVN | Kintz Samuel | Pres, CEO | S - Sale | $27.51 | -14,936 | 1,033,793 | -1% | -$410,867 | |||||
| DM | 2024-10-04 | ELVN | Hohl Benjamin | CFO | S - Sale+OE | $27.51 | -11,488 | 0 | -100% | -$316,014 | |||||
2024-10-04 | ELVN | Heyman Richard A. | Dir | S - Sale | $27.51 | -2,825 | 191,085 | -1% | -$77,704 | ||||||
2024-10-01 | ELVN | Lyssikatos Joseph P | CHIEF SCIENTIFIC OFFICER | S - Sale | $27.54 | -527 | 1,077,409 | 0% | -$14,512 | ||||||
2024-10-01 | ELVN | Kintz Samuel | Pres, CEO | S - Sale | $27.54 | -526 | 1,048,729 | 0% | -$14,485 | ||||||
| D | 2024-10-01 | ELVN | Hohl Benjamin | CFO | S - Sale+OE | $27.54 | -521 | 0 | -100% | -$14,347 | |||||
2024-10-01 | ELVN | Heyman Richard A. | Dir | S - Sale | $27.54 | -518 | 193,910 | 0% | -$14,264 | ||||||
| DM | 2024-09-27 | ELVN | Hohl Benjamin | CFO | S - Sale+OE | $24.61 | -6,250 | 0 | -100% | -$153,829 | |||||
2024-09-16 | ELVN | Heyman Richard A. | Dir | S - Sale | $22.41 | -1,270 | 194,428 | -1% | -$28,458 | ||||||
2024-08-29 | ELVN | Lyssikatos Joseph P | CHIEF SCIENTIFIC OFFICER | S - Sale | $22.49 | -12,000 | 1,077,936 | -1% | -$269,841 | ||||||
| D | 2024-08-27 | ELVN | Hohl Benjamin | CFO | S - Sale+OE | $22.54 | -4,250 | 0 | -100% | -$95,782 | |||||
2024-08-26 | ELVN | Kintz Samuel | Pres, CEO | S - Sale | $22.89 | -12,000 | 1,049,255 | -1% | -$274,718 | ||||||
2024-08-15 | ELVN | Heyman Richard A. | Dir | S - Sale | $23.25 | -1,270 | 195,698 | -1% | -$29,526 | ||||||
2024-07-31 | ELVN | Lyssikatos Joseph P | CHIEF SCIENTIFIC OFFICER | S - Sale | $27.56 | -3,099 | 1,089,936 | 0% | -$85,399 | ||||||
2024-07-31 | ELVN | Kintz Samuel | Pres, CEO | S - Sale | $27.56 | -2,270 | 1,061,255 | 0% | -$62,555 | ||||||
| D | 2024-07-31 | ELVN | Hohl Benjamin | CFO | S - Sale+OE | $27.53 | -991 | 0 | -100% | -$27,281 | |||||
2024-07-31 | ELVN | Heyman Richard A. | Dir | S - Sale | $27.50 | -2,351 | 196,968 | -1% | -$64,663 | ||||||
2024-07-29 | ELVN | Lyssikatos Joseph P | CHIEF SCIENTIFIC OFFICER | S - Sale | $26.70 | -12,000 | 1,093,035 | -1% | -$320,378 | ||||||
| D | 2024-07-29 | ELVN | Hohl Benjamin | CFO | S - Sale+OE | $26.68 | -5,250 | 0 | -100% | -$140,052 | |||||
2024-07-25 | ELVN | Kintz Samuel | Pres, CEO | S - Sale | $24.92 | -12,000 | 1,240,587 | -1% | -$299,073 | ||||||
2024-07-15 | ELVN | Heyman Richard A. | Dir | S - Sale | $24.80 | -1,270 | 199,319 | -1% | -$31,497 | ||||||
| M | 2024-07-12 | ELVN | Patel Anish | COO | S - Sale | $25.06 | -50,000 | 344,027 | -13% | -$1,252,826 | |||||
| D | 2024-07-12 | ELVN | Hohl Benjamin | CFO | S - Sale+OE | $25.07 | -3,000 | 0 | -100% | -$75,195 | |||||
2024-07-01 | ELVN | Lyssikatos Joseph P | CHIEF SCIENTIFIC OFFICER | S - Sale | $22.89 | -12,000 | 1,105,035 | -1% | -$274,736 | ||||||
| D | 2024-06-27 | ELVN | Hohl Benjamin | CFO | S - Sale+OE | $22.57 | -4,250 | 0 | -100% | -$95,922 | |||||
2024-06-25 | ELVN | Kintz Samuel | Pres, CEO | S - Sale | $21.66 | -12,000 | 1,252,587 | -1% | -$259,902 | ||||||
2024-06-17 | ELVN | Heyman Richard A. | Dir | S - Sale | $21.48 | -1,270 | 200,589 | -1% | -$27,278 | ||||||
| D | 2024-06-06 | ELVN | Patel Anish | COO | S - Sale+OE | $20.06 | -1,133 | 394,027 | 0% | -$22,722 | |||||
| D | 2024-05-29 | ELVN | Lyssikatos Joseph P | Chief Scientific Officer | S - Sale+OE | $21.73 | -12,000 | 1,117,035 | -1% | -$260,800 | |||||
| D | 2024-05-28 | ELVN | Kintz Samuel | Pres, CEO | S - Sale+OE | $23.18 | -12,000 | 1,264,587 | -1% | -$278,210 | |||||
| D | 2024-05-28 | ELVN | Hohl Benjamin | CFO | S - Sale+OE | $23.18 | -4,250 | 0 | -100% | -$98,530 | |||||
2024-05-16 | ELVN | Heyman Richard A. | Dir | S - Sale | $23.74 | -1,270 | 201,859 | -1% | -$30,150 | ||||||
2024-05-16 | ELVN | Gupta Rishi | Dir, 10% | S - Sale | $22.14 | -1,033,300 | 7,663,349 | -12% | -$22,877,262 | ||||||
2024-05-16 | ELVN | Orbimed Advisors LLC | Dir, 10% | S - Sale | $22.14 | -1,033,300 | 7,663,349 | -12% | -$22,877,262 | ||||||
| D | 2024-05-14 | ELVN | Patel Anish | COO | S - Sale+OE | $25.00 | -1,107 | 394,027 | 0% | -$27,675 | |||||
| D | 2024-05-09 | ELVN | Patel Anish | COO | S - Sale+OE | $25.06 | -260 | 394,027 | 0% | -$6,515 | |||||
| D | 2024-05-06 | ELVN | Patel Anish | COO | S - Sale+OE | $22.72 | -4,875 | 394,027 | -1% | -$110,769 | |||||
| D | 2024-05-03 | ELVN | Hohl Benjamin | CFO | S - Sale+OE | $22.50 | -1,000 | 0 | -100% | -$22,500 | |||||
| D | 2024-04-29 | ELVN | Lyssikatos Joseph P | Chief Scientific Officer | S - Sale+OE | $17.92 | -12,000 | 1,117,035 | -1% | -$214,988 | |||||
| D | 2024-04-29 | ELVN | Hohl Benjamin | CFO | S - Sale+OE | $16.97 | -3,250 | 0 | -100% | -$55,165 | |||||
| D | 2024-04-25 | ELVN | Kintz Samuel | Pres, CEO | S - Sale+OE | $16.89 | -12,000 | 1,264,587 | -1% | -$202,700 | |||||
| D | 2024-04-11 | ELVN | Patel Anish | COO | S - Sale+OE | $25.03 | -17,500 | 394,027 | -4% | -$438,099 | |||||
| D | 2024-04-11 | ELVN | Lyssikatos Joseph P | Chief Scientific Officer | S - Sale+OE | $25.04 | -30,000 | 1,117,035 | -3% | -$751,332 | |||||
| D | 2024-04-11 | ELVN | Kintz Samuel | Pres, CEO | S - Sale+OE | $25.04 | -47,709 | 1,264,587 | -4% | -$1,194,700 | |||||
| D | 2024-04-11 | ELVN | Hohl Benjamin | CFO | S - Sale+OE | $24.72 | -14,000 | 0 | -100% | -$346,149 | |||||
| M | 2024-04-11 | ELVN | Heyman Richard A. | Dir | S - Sale | $24.11 | -6,964 | 203,129 | -3% | -$167,888 | |||||
| D | 2024-04-11 | ELVN | Collins Helen Louise | Chief Medical Officer | S - Sale+OE | $25.07 | -20,000 | 0 | -100% | -$501,478 | |||||
| DM | 2024-04-10 | ELVN | Ballal Rahul D. | Dir | S - Sale+OE | $23.36 | -67,000 | 22,341 | -75% | -$1,564,812 | |||||
2024-04-08 | ELVN | Patel Anish | COO | S - Sale | $18.60 | -4,875 | 396,624 | -1% | -$90,687 | ||||||
| D | 2024-04-04 | ELVN | Ballal Rahul D. | Dir | S - Sale+OE | $19.15 | -3,485 | 22,341 | -13% | -$66,729 | |||||
| D | 2024-04-01 | ELVN | Ballal Rahul D. | Dir | S - Sale+OE | $19.08 | -3,237 | 22,341 | -13% | -$61,758 | |||||
| D | 2024-04-01 | ELVN | Lyssikatos Joseph P | Chief Scientific Officer | S - Sale+OE | $18.60 | -12,000 | 1,117,035 | -1% | -$223,146 | |||||
| D | 2024-03-27 | ELVN | Hohl Benjamin | CFO | S - Sale+OE | $18.25 | -3,250 | 0 | -100% | -$59,302 | |||||
| D | 2024-03-25 | ELVN | Kintz Samuel | Pres, CEO | S - Sale+OE | $17.56 | -12,000 | 1,264,587 | -1% | -$210,661 | |||||
| D | 2024-03-20 | ELVN | Ballal Rahul D. | Dir | S - Sale+OE | $19.16 | -13,278 | 22,341 | -37% | -$254,462 | |||||
2024-03-19 | ELVN | Heyman Richard A. | Dir | S - Sale | $14.50 | -1,270 | 210,093 | -1% | -$18,419 | ||||||
2024-03-06 | ELVN | Patel Anish | COO | S - Sale | $15.64 | -4,875 | 401,499 | -1% | -$76,239 | ||||||
| D | 2024-02-29 | ELVN | Lyssikatos Joseph P | Chief Scientific Officer | S - Sale+OE | $16.42 | -12,000 | 1,117,035 | -1% | -$197,006 | |||||
| D | 2024-02-27 | ELVN | Hohl Benjamin | CFO | S - Sale+OE | $16.97 | -3,250 | 0 | -100% | -$55,163 | |||||
2024-02-15 | ELVN | Heyman Richard A. | Dir | S - Sale | $17.42 | -1,270 | 211,363 | -1% | -$22,117 | ||||||
2024-02-14 | ELVN | 5Am Partners Vi, LLC | 10% | S - Sale | $14.90 | -825,000 | 3,835,975 | -18% | -$12,292,500 | ||||||
2024-02-06 | ELVN | Patel Anish | COO | S - Sale | $15.11 | -4,875 | 406,374 | -1% | -$73,658 | ||||||
2024-01-31 | ELVN | 5Am Partners Vi, LLC | 10% | S - Sale | $15.00 | -500,000 | 4,660,975 | -10% | -$7,500,000 | ||||||
2024-01-30 | ELVN | Heyman Richard A. | Dir | S - Sale | $16.41 | -1,270 | 212,633 | -1% | -$20,840 | ||||||
| D | 2024-01-29 | ELVN | Lyssikatos Joseph P | Chief Scientific Officer | S - Sale+OE | $15.85 | -12,000 | 1,117,035 | -1% | -$190,256 | |||||
| D | 2024-01-29 | ELVN | Hohl Benjamin | CFO | S - Sale+OE | $15.81 | -3,250 | 0 | -100% | -$51,388 | |||||
| D | 2024-01-25 | ELVN | Kintz Samuel | Pres, CEO | S - Sale+OE | $15.69 | -12,000 | 1,264,587 | -1% | -$188,229 | |||||
2024-01-22 | ELVN | Patel Anish | COO | S - Sale | $15.14 | -4,875 | 411,249 | -1% | -$73,783 | ||||||
| D | 2023-12-29 | ELVN | Lyssikatos Joseph P | Chief Scientific Officer | S - Sale+OE | $14.28 | -12,000 | 1,117,035 | -1% | -$171,381 | |||||
| M | 2023-12-28 | ELVN | Patel Anish | COO | S - Sale | $15.02 | -13,540 | 416,124 | -3% | -$203,348 | |||||
| DM | 2023-12-28 | ELVN | Hohl Benjamin | CFO | S - Sale+OE | $15.02 | -11,870 | 0 | -100% | -$178,327 | |||||
| D | 2023-12-26 | ELVN | Kintz Samuel | Pres, CEO | S - Sale+OE | $14.64 | -12,000 | 1,264,587 | -1% | -$175,709 | |||||
| M | 2023-12-22 | ELVN | Patel Anish | COO | S - Sale | $15.03 | -1,085 | 429,664 | 0% | -$16,306 | |||||
| DM | 2023-12-22 | ELVN | Hohl Benjamin | CFO | S - Sale+OE | $15.07 | -1,130 | 0 | -100% | -$17,025 | |||||
| DM | 2023-12-21 | ELVN | Lyssikatos Joseph P | Chief Scientific Officer | S - Sale+OE | $13.07 | -6,566 | 1,117,035 | -1% | -$85,790 | |||||
| DM | 2023-12-21 | ELVN | Kintz Samuel | Pres, CEO | S - Sale+OE | $13.05 | -8,195 | 1,264,587 | -1% | -$106,915 | |||||
| M | 2023-12-21 | ELVN | Heyman Richard A. | Dir | S - Sale | $13.00 | -216 | 213,903 | 0% | -$2,808 | |||||
| D | 2023-12-20 | ELVN | Kintz Samuel | Pres, CEO | S - Sale+OE | $13.01 | -7,779 | 1,264,587 | -1% | -$101,238 | |||||
| DM | 2023-12-19 | ELVN | Lyssikatos Joseph P | Chief Scientific Officer | S - Sale+OE | $13.01 | -8,888 | 1,117,035 | -1% | -$115,646 | |||||
| M | 2023-12-19 | ELVN | Heyman Richard A. | Dir | S - Sale | $13.02 | -4,280 | 214,119 | -2% | -$55,727 | |||||
| D | 2023-11-03 | ELVN | Lyssikatos Joseph P | Chief Scientific Officer | S - Sale+OE | $13.08 | -8,546 | 1,117,035 | -1% | -$111,751 | |||||
| D | 2023-11-03 | ELVN | Kintz Samuel | Pres, CEO | S - Sale+OE | $13.08 | -8,026 | 1,264,587 | -1% | -$104,999 | |||||
| D | 2023-09-29 | ELVN | Lyssikatos Joseph P | Chief Scientific Officer | S - Sale+OE | $13.62 | -12,000 | 1,117,035 | -1% | -$163,498 | |||||
2023-09-26 | ELVN | 5Am Partners Vi, LLC | 10% | S - Sale | $15.00 | -197,500 | 5,160,975 | -4% | -$2,962,500 | ||||||
| D | 2023-09-25 | ELVN | Kintz Samuel | Pres, CEO | S - Sale+OE | $13.81 | -12,000 | 1,264,587 | -1% | -$165,691 | |||||
2023-08-24 | ELVN | 5Am Partners Vi, LLC | 10% | S - Sale | $16.00 | -440,000 | 5,358,475 | -8% | -$7,040,000 | ||||||
2023-02-23 | ELVN | Commodore Capital LP | 10% | P - Purchase | $22.07 | +622 | 1,448,640 | 0% | +$13,723 | ||||||
| M | 2023-02-21 | IMRA | Commodore Capital LP | 10% | P - Purchase | $5.15 | +31,759 | 2,872,513 | +1% | +$163,498 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |